Andrew Pierce

Andrew Pierce is an accomplished professional in the field of translational medicine and oncology, currently serving as Senior Vice President - Discovery & Development at Owkin since April 2024. Prior experience includes roles as Vice President - Translational Biology at Crescendo Biologics Limited, and Associate Director - Translational Medicine Oncology at AstraZeneca, where Andrew led a molecular pathology laboratory and developed clinical biomarker strategies. Andrew's career began with postdoctoral research at Duke University and Memorial Sloan-Kettering Cancer Center, focusing on DNA repair mechanisms, followed by an academic position as Assistant Professor at the University of Kentucky. Andrew holds a Ph.D. in molecular genetics from the University of North Carolina at Chapel Hill and a B.Sc. (honors) in Molecular and Cellular Biology from the University of Toronto.